Septriyanto Dirgantara

Septriyanto Dirgantara

Auto-generated profile, based on publicly available information

Septriyanto Dirgantara

Bandung Inst Technol, Sch Pharm, Dept Pharmaceut Biol, Jl Ganesa 10, Bandung 40132, West Java, Indonesia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in Pharmacia
Verified
Journal Article
Open access
PDF file
SDSeptriyanto Dirgantara
Septriyanto Dirgantara
MIMuhamad Insanu
Muhamad Insanu
IFIrda Fidrianny
Irda Fidrianny
Some medicinal plants from Papua have been used traditionally as hyperuricemia and antioxidant agents for many ethnic in Papua Islands. The present study aims to evaluate inhibitory xanthine oxidase, antioxidative activities, total phenolic, and total flavonoid of five Papua selected medicinal plants, Myrmecodia beccarii, Villebrunea rubescens, Breynia cernua, Bridelia spp. and Dodonaea viscosa. Preliminary phytochemical screening revealed the presence of flavonoids and phenolic compounds with TLC-densitometric analysis, which is responsible for the biological activities of different plant extracts. Antioxidant was tested by 2,2- diphenyl-1- picrylhydrazyl (DPPH) and cupric ion antioxidant capacity (CUPRAC) methods and expressed as the Antioxidant Activity Index (AAI). Xanthine oxidase inhibitory (XOI) activity was evaluated by a spectrophotometer. The ethyl acetate of Myrmecodia beccarii extract (MEA) showed the highest antioxidative and XOI activity. The MEA extract from Papua may be developed as a new potential source of antioxidant and xanthine oxidase inhibitory agent.

1 January 2022 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
SDSeptriyanto Dirgantara
Septriyanto Dirgantara
MIMuhamad Insanu
Muhamad Insanu
IFIrda Fidrianny
Irda Fidrianny
BACKGROUND: The Myrmecodia genus belongs to the Rubiaceae family, which has the characteristic of an epiphytic plant. This genus spread from Malaysia, through the Philippines, Sumatra, Borneo, Java, New Guinea (Papua), Cape York to the Solomon Islands and Pacific region. It has been empirically proven to treat gout, inflammation, muscle pain relief, strengthen the body’s immunity, and cancer treatment. AIM: This article reviewed the scientific work about the Myrmecodia genus concerning their traditional uses, phytochemical compounds, and pharmacological activities of Myrmecodia. METHODS: The sources were from the scientific literature online database, including Science Direct, PubMed, and Google Scholar between 1978 and 2021. Furthermore, 112 articles were collected, while 61 full-text were assessed for eligibility. RESULTS: The Myrmecodia extract has many pharmacological activities, namely antioxidant, antibacterial, cytotoxic, and anticancer. CONCLUSION: Moreover, this review may be used as scientific literature for the next investigations on the genus Myrmecodia, especially regarding pharmacological properties such as in vitro and in vivo studies and isolation of the active compounds.

19 August 2025 in Food and Humanity
Verified
Journal Article
Closed access
ASArif Setiawansyah
Arif Setiawansyah
BFBella Fiolita
Bella Fiolita
SASandra Agatha
Sandra Agatha
RSRina Se Sitindaon
Rina Se Sitindaon
MRMuhammad Andre Reynaldi
Muhammad Andre Reynaldi
SDSeptriyanto Dirgantara
Septriyanto Dirgantara